Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RSP vs MRNA✓SelectedUSD · MRNARSP vs MRNA performance historyLatest closeAs of-1.01%11/16
Stock and ETF performance explorer

RSP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+158.8%
MRNA return
+878.5%
Excess return
-719.7%
Maximum drawdown
-39.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.0%-3.6%+2.6%-0.9%
7D-0.9%-20.0%+19.1%-0.2%
30D+2.3%-1.3%+3.5%+2.2%
3M-1.4%+240.0%-241.3%-7.8%
6M+9.4%+339.0%-329.5%+0.5%
YTD+15.7%+630.0%-614.3%+3.0%
1Y+18.7%+769.1%-750.3%+4.6%
3Y+58.7%+181.2%-122.5%+44.8%
5Y+46.8%-8.1%+54.9%+36.8%
All+158.8%+878.5%-719.7%+128.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling